Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0146 | 0.2803 | 0.2803 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0421 | 1 | 1 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0146 | 0.2803 | 0.2803 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0146 | 0.2803 | 0.2803 |
Plasmodium falciparum | thioredoxin reductase | 0.0146 | 0.2803 | 0.2803 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0146 | 0.2803 | 0.2803 |
Echinococcus granulosus | tm gpcr rhodopsin | 0.0387 | 0.9108 | 0.9108 |
Entamoeba histolytica | thioredoxin reductase, putative | 0.0039 | 0 | 0.5 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0146 | 0.2803 | 0.2803 |
Trypanosoma brucei | trypanothione reductase | 0.0421 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0146 | 0.2803 | 0.2803 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0146 | 0.2803 | 0.2803 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0107 | 0.179 | 0.179 |
Plasmodium falciparum | glutathione reductase | 0.0421 | 1 | 1 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0146 | 0.2803 | 1 |
Leishmania major | trypanothione reductase | 0.0421 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0146 | 0.2803 | 0.2803 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0146 | 0.2803 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0146 | 0.2803 | 1 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0146 | 0.2803 | 0.2803 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0421 | 1 | 1 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0146 | 0.2803 | 0.2803 |
Toxoplasma gondii | thioredoxin reductase | 0.0421 | 1 | 1 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0107 | 0.179 | 0.179 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0146 | 0.2803 | 0.2803 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0146 | 0.2803 | 0.2803 |
Plasmodium falciparum | thioredoxin reductase | 0.0421 | 1 | 1 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0146 | 0.2803 | 0.2803 |
Brugia malayi | Thioredoxin reductase | 0.0421 | 1 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0421 | 1 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0146 | 0.2803 | 0.2803 |
Entamoeba histolytica | disulphide oxidoreductase, putative | 0.0039 | 0 | 0.5 |
Entamoeba histolytica | NAD(FAD)-dependent dehydrogenase, putative | 0.0039 | 0 | 0.5 |
Plasmodium vivax | glutathione reductase, putative | 0.0421 | 1 | 1 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0146 | 0.2803 | 0.2803 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0146 | 0.2803 | 0.2803 |
Entamoeba histolytica | dihydropyrimidine dehydrogenase, putative | 0.0039 | 0 | 0.5 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0146 | 0.2803 | 0.2803 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0146 | 0.2803 | 0.2803 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0146 | 0.2803 | 1 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0146 | 0.2803 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0146 | 0.2803 | 0.2803 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0146 | 0.2803 | 0.2803 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0146 | 0.2803 | 0.2803 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0146 | 0.2803 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0146 | 0.2803 | 0.2803 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0146 | 0.2803 | 0.2803 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0146 | 0.2803 | 0.2803 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0421 | 1 | 1 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.0387 | 0.9108 | 0.9108 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0146 | 0.2803 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0421 | 1 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0421 | 1 | 1 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0146 | 0.2803 | 0.2803 |
Entamoeba histolytica | pyridine nucleotide-disulfide oxidoreductase family protein | 0.0039 | 0 | 0.5 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0146 | 0.2803 | 0.2803 |
Entamoeba histolytica | glutamate synthase beta subunit, putative | 0.0039 | 0 | 0.5 |
Treponema pallidum | NADH oxidase | 0.0146 | 0.2803 | 1 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0146 | 0.2803 | 0.2803 |
Entamoeba histolytica | glutamate synthase beta subunit, putative | 0.0039 | 0 | 0.5 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0146 | 0.2803 | 0.2803 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0146 | 0.2803 | 0.2803 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0146 | 0.2803 | 0.2803 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0421 | 1 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0146 | 0.2803 | 0.2803 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0146 | 0.2803 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0146 | 0.2803 | 1 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0146 | 0.2803 | 1 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0146 | 0.2803 | 0.2803 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.